CHS Chairman and CEO Wayne Smith and CFO Larry Cash shared that plan on a second-quarter earnings call Wednesday. CHS plans to sell the 12 undisclosed hospitals and some other non-hospital operations, which have combined annual revenues of $1.45 billion, in five separate transactions. The company expects the sale of the facilities to trim its debt by $850 million.
After accounting for one-time adjustments, CHS ended the second quarter of 2016 with a $1.4 billion loss, compared with a profit of $117 million in the same period of the year prior.
More articles on healthcare finance:
Physicians Realty Trust reports $680M in Q2 investment activity, spurred by CHI building agreements
This week’s 5 must-reads for hospital CFOs
6 characteristics of consumer-friendly revenue cycles
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
